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Abstract
Background: Inhibitors of the protease calpain are known to have selectively toxic effects on
Plasmodium falciparum. The enzyme has a natural inhibitor calpastatin and in eukaryotes is
responsible for turnover of proteins containing short sequences enriched in certain amino acids
(PEST sequences). The genome of P. falciparum was searched for this protease, its natural inhibitor
and putative substrates.
Methods: The publicly available P. falciparum genome was found to have too many errors to permit
reliable analysis. An earlier annotation of chromosome 2 was instead examined. PEST scores were
determined for all annotated proteins. The published genome was searched for calpain and
calpastatin homologs.
Results: Typical PEST sequences were found in 13% of the proteins on chromosome 2, including
a surprising number of cell-surface proteins. The annotated calpain gene has a non-biological
"intron" that appears to have been created to avoid an unrecognized frameshift. Only the catalytic
domain has significant similarity with the vertebrate calpains. No calpastatin homologs were found
in the published annotation.
Conclusion: A calpain gene is present in the genome and many putative substrates of this enzyme
have been found. Calpastatin homologs may be found once the re-annotation is completed. Given
the selective toxicity of calpain inhibitors, this enzyme may be worth exploring further as a potential
drug target.
Background
Calpain (EC 3.4.22.17) is a Ca2+-dependent cysteine pro-
tease first isolated in 1978, with a pH optimum between
7.0 and 8.0. There are at least 15 distinct calpain genes
present in the human genome and several have a number
of isoforms (up to 10). Along with the ATP-dependent
proteasome, calpain appears to be responsible for the
majority of non-lysosomal targeted proteolysis. It is a
member of the papain superfamily [2] a group of pro-
teases that includes papain, calpain, streptopain, ubiqui-
tin-specific peptidases and many families of viral cysteine
endopeptidases. Calpain is a protein of ancient origin
with homologues found in vertebrates, insects, crusta-
ceans, nematodes, fungi, higher plants, Dictyostelium,
kinetoplastid Protozoa, and bacteria [2] and evolved from
a gene fusion event between an N-terminal cysteine pro-
tease and a C-terminal calmodulin-like protein, an event
predating the eukaryote/prokaryote divergence [3].
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The enzyme cleaves preferentially on the C-terminal side
of tyrosine, methionine or arginine, preceded by leucine
or valine (i.e. P1 = Y, M, or R; P2 = L or V according to the
established nomenclature [4]). Calpain occurs either as a
heterodimer with a small regulatory subunit and a large
catalytic subunit or as the catalytic subunit alone [5]. It
has been crystallised and its structure has been solved for
several species [6,7]. The active site consists of a conserved
triad of cysteine, asparagine and histidine. The catalytic
domain is divided into two subdomains (2a and 2b) with
the cysteine residue lying in domain 2a and the histidine
and asparagine in 2b. Calpain has a natural monomeric
protein inhibitor, calpastatin [8]. In the presence of Ca2+,
calpain undergoes a conformational change, dissociates
from or cleaves the associated calpastatin and finally
cleaves its own first domain to become fully active.
Substrates of this enzyme appear to be recognised princi-
pally by the presence of PEST sequence(s) within the pro-
tein [9,10] although exceptions are known [11]. PEST
sequences were first described in 1986 [12] and are short
subsequences (usually 10 – 60 residues) within proteins
that are bounded by but do not contain basic residues (H,
K or R), and are enriched in proline (P), glutamate (E),
serine (S), threonine (T) and aspartate (D) residues. An
algorithm (the PEST-find score) has been described for
assessing the significance of such subsequences: a score of
5 or greater is regarded as significant. PEST sequences are
found in ~10% of all cellular proteins in the organisms
analysed to date and are typically found in highly regu-
lated proteins. PEST +ve (PEST sequence containing) pro-
teins typically have short half lives (0.5 to 2 hours) in
intact cells compared with most other proteins (>24
hours). In PEST +ve proteins, removal or disruption of the
PEST sequence increases the protein's half life to more
"normal" values while insertion or creation of a new PEST
sequence within a PEST -ve (PEST sequence free) protein
decreases that protein's half life to a value typical of a PEST
+ve protein.
Two papers describe the effects of calpain inhibitors on P.
falciparum. The first [13] described the effect of calpain
inhibitors on the invasion of erythrocytes. The authors
found the inhibitors used were ~100 times as potent (IC50
~10-7 M) than the other protease inhibitors (chymostatin,
leupeptin, pepstatin A and bestatin) examined. Erythro-
cytes normally contain only calpain 2 and it was not clear
at the time if the effect of these inhibitors was as a result
of inhibition of the parasite's and/or of the erythrocyte's
calpain. This has been clarified recently by Hanspal et al.
[14] who reinvestigated this effect in calpain 2 knock-out
mice. The mouse erythrocytes were shown to have no
detectable calpain activity but still supported the invasion
and growth of P. falciparum in culture. Calpain inhibition
again prevented re-invasion. A third paper [15] has shown
that removal of Ca2+ from the growth medium results in
growth arrest in the late trophozoite stage and failure to
invade erythrocytes – findings consistent with a role for
calpain in the parasite life cycle. With the recent publica-
tion of the entire genome [16–18] a search for the calpain
and calpastatin genes or their homologs and PEST +ve
proteins was undertaken to investigate this further.
Methods
The flat files (version 2) were downloaded from the Plas-
moDB [19] web site http://www.plasmodb.org/. The gene
coordinates extracted and then used to build a database of
the genes. Multiple errors were found in the annotation
including an anomalous start (AAA, CAC, GTA, TAG) and
termination codons (AAT, ATA, AAG, CTT, GAA, GGG,
TTC, TTT), introns of length 2 and 5 bases, unusual
intronic splice sites (TA, TT), introns with exceptionally
high GC content (up to 44%) and the absence of a
number experimentally known genes. In view of these
findings, the alternative annotation of chromosome 2
[20], as revised in September 2002 http://
www.wehi.edu.au/MalDB-www/chr2list.html/, was used.
The PEST score was calculated with the standard algo-
rithm [12]. Sequences of 10+ residues bounded by, but
not containing basic residues (H, K or R), are first identi-
fied. The mole percent (MP) of this subsequence is then
determined after subtracting one mole equivalent of P, E/
D and S/T. The normalised hydrophobicity value is the
value of the Kyte-Doolittle index [21] for that residue mul-
tiplied by 10 plus 45, giving values between 0 and 90.
Stellwagen http://emb1.bcc.univie.ac.at/embnet/tools/
bio/PESTfind/ has suggested that a value of 58 for tyrosine
rather than 32 as originally given gives a more reliable
PEST score: the former value was used here. The average
hydrophobicity (Ho) of a subsequence is determined by
summing the MP of each residue and its normalised
hydrophobicity value. The PEST-find score is 0.55 (MP) -
0.5 (Ho). (The original paper has a misprint with PEST-
find = 0.5 (MP) - 0.5(Ho))
Results
The revised annotation of chromosome 2 [20] predicts
206 protein-encoding genes. Forty-four PEST sequences
with scores > 5 were found with lengths varying from 12
to 94 (30.3 +/-19.9) amino acids in 27 (13.1%) proteins.
The proteins fall into four groups (a) hypothetical pro-
teins – 4 (b) DNA binding proteins – 2 (origin recognition
complex subunit 5 and chromatin-binding protein) (c)
metabolic proteins – 3 (a phosphatase, ribosome releas-
ing factor, ATP-dependent acyl-CoA synthetase) and (d)
cell surface associated proteins – 18 (erythrocyte mem-
brane proteins (EMP) 1 and 3, rifins, merozoite surface
proteins (MSP) 2 and 5, serine-repeat antigens, transmis-
sion blocking target antigen pfs230 and two predictedMalaria Journal 2003, 2 http://www.malariajournal.com/content/2/1/16
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secreted proteins). The PEST sequences occur throughout
proteins with some bias towards the N-terminal end (60%
are found in the first half). The PEST +ve proteins had sig-
nificantly lower predicted pIs (6.63 and 8.13 respectively:
t = 3.86, p < 0.0005) and were significantly longer (1181
and 731 amino acids respectively: t = 2.91, p < 0.004)
than the average. 18 (66.7%) of the PEST +ve proteins
have introns, a figure slightly higher than the mean
(57.5%). There was no significant difference in the
number of introns per protein (1.12 and 1.32, t = -0.16, p
> 0.8).
On chromosome 13, a putative calpain gene
(MAL13P1.310) containing a single intron was found.
This gene has been discussed in a paper by Wu et al. [22].
The gene is unusually large (2047 residues) and has a bio-
logically implausible "intron" that appears to have been
created to avoid an unrecognised frameshift [see Addi-
tional file: 1]. The 5' end of the gene contains a low-com-
Table 1: PEST sequences on chromosome 2.
Gene ID Annotation Sequence start* Sequence end* PEST score
PFB0010w tigr pfemp1 1202 1213 6.40
PFB0010w tigr pfemp1 815 831 6.79
PFB0010w tigr pfemp1 917 948 8.25
PFB0010w tigr pfemp1 736 759 5.92
PFB0010w tigr pfemp1 764 796 25.89
PFB0030c tigr rifin 22 36 7.10
PFB0040c tigr rifin 30 56 5.04
PFB0095c pfemp3 tigr 526 541 5.73
PFB0095c pfemp3 tigr 735 755 5.76
PFB0250w tigr hypothetical protein tigr merozoite surface antigen 621 635 15.65
PFB0300c msp-2 tigr merozoite surface antigen 41 100 5.46
PFB0305c msp-5 (egf domain) tigr merozoite surface antigen 109 128 12.31
PFB0305c msp-5 (egf domain) tigr sera antigen/papain-like 135 168 9.93
PFB0330c protease with active cys vbc sera antigen/papain-like 40 68 10.38
PFB0335c protease with active cys vbc sera antigen/papain-like 100 130 6.09
PFB0335c protease with active cys vbc sera antigen/papain-like 144 163 9.86
PFB0335c protease with active cys vbc sera antigen/papain-like 259 275 12.43
PFB0335c protease with active cys tigr sera antigen/papain-like 487 502 11.12
PFB0340c protease with active cys tigr sera antigen/papain-like 21 89 7.04
PFB0345c protease with active ser tigr sera antigen/papain-like 789 853 12.88
PFB0345c protease with active ser tigr sera antigen/papain-like 71 95 18.98
PFB0345c protease with active ser tigr sera antigen/papain-like 142 164 7.91
PFB0350c protease with active ser tigr sera antigen/papain-like 21 37 7.05
PFB0350c protease with active ser tigr sera antigen/papain-like 70 110 6.80
PFB0350c protease with active ser vbc sera antigen/papain-like 50 63 11.42
PFB0360c protease with active ser tigr phosphatase (acid phosphatase family) 867 888 9.78
PFB0380c tigr ribosome releasing factor 332 400 6.69
PFB0390w (oo tp) tigr predicted membrane 123 216 21.33
PFB0395w associated protein tigr transmission blocking 222 235 9.06
PFB0405w target antigen pfs230 1601 1638 8.96
PFB0460c vbc qimr hypothetical protein 1835 1852 15.52
PFB0560w vbc hypothetical protein tigr predicted secreted protein 3631 3654 11.91
PFB0570w (thrombospondin domain) vbc predicted secreted 44 74 6.52
PFB0675w protein tigr ATP-dept. acyl-coa 338 354 9.43
PFB0685c synthetase (tp) 646 661 8.69
PFB0700c tigr hypothetical protein tigr origin recognition cmplx 692 767 12.25
PFB0720c subunit 5 (ATPase) tigr chromatin-binding protein 194 226 17.27
PFB0875c (ski/snw family) 141 165 8.91
PFB0970c vbc hypothetical protein 230 246 10.43
PFB0970c vbc hypothetical protein 282 300 7.08
PFB1055c tigr pfemp1 var 822 890 24.33
PFB1055c tigr pfemp1 var 2138 2153 5.90
PFB1055c tigr pfemp1 var 1673 1694 15.59
* Residue number within sequence of polypeptideMalaria Journal 2003, 2 http://www.malariajournal.com/content/2/1/16
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plexity region and is more than twice the size of other
known calpains (generally 600 – 800 residues). The cata-
lytic domain is the only part of the enzyme with homol-
ogy with the vertebrate enzymes and in the P. falciparum
gene this domain is unusually distant from the N-termi-
nus (residues 1002–1470): in other organisms the active
site lies within 150 residues of the N-terminus. It seems
probable that a fusion event has occurred at the original 5'
end of the calpain gene with a second, to date, unidenti-
fied gene. If activation of the P. falciparum calpain is simi-
lar to that in other organisms, the 5' domain would be
removed during activation and this new element may be
responsible for the selective toxicity of the inhibitors or
may play some regulatory role.
Discussion
The errors in the published genome were unexpected. A
re-annotation of the genome will shortly be completed
and it is intended that it will be possible to compare the
two annotations (Huestis R., personal communication).
PEST sequences have not been previously described in P.
falciparum and the sequences found here appear to be very
similar to those known in other organisms. The presence
of PEST sequences in hypothetical proteins, DNA-binding
proteins [23] and proteins involved in intermediary
metabolism was expected, while the finding that the
majority of PEST +ve sequences were surface exposed pro-
teins was not. The greater length and the lower predicted
pI of the PEST +ve proteins and locational bias of the PEST
sequences towards the N-terminus are consistent with ear-
lier findings [12].
Several families of surface exposed proteins are present in
chromosome 2: PEST sequences were found in all PfEMPs,
MSP 2 and 5, a subset of SERA antigens (6 of 8) and rifins
(2 of 7). Cytoadherence-linked asexual genes (CLAGs)
and sub-telomeric variable open-reading frames (STE-
VORs) were all PEST -ve. The presence of PEST sequences
in a subset of SERA and rifins is suggestive of differential
processing or cellular turnover and may shed some light
on the reason for the large number of these genes in the
genome.
The presence of PEST sequences in surface exposed pro-
teins prompted a search for these sequences in other pro-
teins known to be involved in merozoite invasion. MSP-1
and -2, the SERAs, and erythrocyte binding antigen (EBA)-
175 are PEST +ve while apical membrane antigen (AMA)-
1, rhoptry associated protein (RAP)-1, -2 and -3, MAEBL,
merozoite capping protein-1 and acidic/basic repeat anti-
gen (ABRA) are PEST -ve. Spectrin, band 4.1 and ankyrin
are PEST +ve erythrocyte proteins known to be bound by
P. faciparum merozoites during the invasion process [25].
Band 3, another PEST +ve erythrocyte protein, is elimi-
nated from the site of contact with the merozoite [26]. The
involvement of calpain in other cell fusion reactions [24]
and the presence of PEST +ve membrane proteins suggest
that this system may be involved in cell adhesion proc-
esses in P. falciparum.
As the parasite progresses from the trophozoite to the sch-
izont stage, there is a thirty-fold increase in the level of
transcription of calpain [22]. The erythrocyte normally
maintains a submicromolar intracellular Ca2+concentra-
tion which rises thirty-fold as the parasite matures. [27]
Given the presence of a PEST sequence in DNA origin rec-
ognition complex protein and the effects on Ca2+ removal
on trophozoite-to-schizont progression, it is tempting to
speculate that the lack of Ca2+ may inhibit calpain activa-
tion and that this is responsible for the effects seen here
[28–32]. Bearing in mind a report for a central role for fal-
cipain 1 in merozoite biology [33], the increase in tran-
scriptional levels seen in the schizont and the effect of
inhibitors on erythrocyte invasion suggest that calpain too
may play a role here.
The P. falciparum calpain gene differs significantly from
those found to date in vertebrates and this may partly
explain the selective toxicity of the inhibitors. There are
many calpain inhibitors presently available and the
majority of these are small peptides that can be freeze-
dried and stored at room temperature. Several have been
used in Phase 2 human trials for treatment of myocardial
infarction, stroke and cancer. Given the need for novel
drugs to treat malaria, the selective toxicity of these inhib-
itors, several known crystal structures and the possibility
of recognising probable target proteins and gene
sequence, these agents may be worth exploring further.
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